The trial led by researcher Professor Nicholas van As from the Royal Marsden Hospital says it’s “outstanding” and fantastic” for patients.

Doses can be cut by three quarters, meaning five larger doses is enough, rather than the usual twenty.

Prostate Cancer UK say the finding has the potential to save time and money for the NHS, while still giving men the best outcomes.